Pembrolizumab in relapsed or refractory primary mediastinal large B-cell lymphoma: final analysis of KEYNOTE-170.
Zinzani PL, Thieblemont C, Melnichenko V, Bouabdallah K, Walewski J, Majlis A, Fogliatto L, Garcia-Sancho AM, Christian B, Gulbas Z, Özcan M, Perini GF, Ghesquieres H, Shipp MA, Thompson S, Chakraborty S, Marinello P, Armand P.
Zinzani PL, et al. Among authors: chakraborty s.
Blood. 2023 Jul 13;142(2):141-145. doi: 10.1182/blood.2022019340.
Blood. 2023.
PMID: 37130017
Free PMC article.
Clinical Trial.